Brookmeyer R, Quinn TC. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. American Journal of Epidemiology
1995; 141: 166–172.
Busch MP, et al.
Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS
2010; 24: 2763–2771.
Janssen RS, et al.
New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. Journal of the American Medical Association
1998; 280: 42–48.
Incidence Assay Citical Path Working Group. More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Medicine
2011; 8: e1001045.
Parekh BS, et al.
Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Research and Human Retroviruses
2002; 18: 295–307.
Duong YT, et al.
Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS ONE
2012; 7: e33328.
Kimanga DO, et al.
Prevalence and incidence of HIV infection, trends, and risk factors among persons aged 15–64 years in Kenya: results from a nationally representative study. Journal of Acquired Immune Deficiency Syndrome
2014; 66 (Suppl. 1): S13–26.
Rehle T, et al.
A comparison of South African national HIV incidence estimates: a critical appraisal of different methods. PLoS ONE
2015; 10: e0133255.
UNAIDS/WHO Working Group on Global HIV/AIDS and STI surveillance. When and how to use assays for recent infection to estimate HIV incidence at a population level, 2011.
UNAIDS/WHO. Technical update on HIV incidence assays for surveillance and monitoring purposes, 2015.
Hargrove JW. BED estimates of HIV incidence must be adjusted. AIDS
2009; 23: 2061–2062; author reply 2066–2068.
Hargrove JW, et al.
Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS
2008; 22: 511–518.
Kassanjee R, et al.
A new general biomarker-based incidence estimator. Epidemiology. 2012; 23: 721–728.
McDougal JS. BED estimates of HIV incidence must be adjusted. AIDS
2009; 23: 2064–2065; author reply 2066–2068.
McWalter TA, Welte A. A comparison of biomarker based incidence estimators. PLoS ONE
2009; 4: e7368.
Wang R, Lagakos SW. On the use of adjusted cross-sectional estimators of HIV incidence. Journal of Acquired Immune Deficiency Syndrome
2009; 52: 538–547.
Welte A, McWalter TA, Barnighausen T. A Simplified formula for inferring HIV incidence from cross-sectional surveys using a test for recent infection. AIDS Research and Human Retroviruses
2009; 25: 125–126.
Welte A, McWalter TA, Barnighausen T. Reply to ‘Should biomarker estimates of HIV incidence be adjusted?’. AIDS
2009; 23: 2062–2063; author reply 2066–2068.
Kassanjee R, et al. The performance of candidate assays to detect recent HIV infection for cross-sectional estimation: An independent comparative evaluation. Conference on Retroviruses and Opportunistic Infections, Atlanta 2013, p. 1056.
Andersson E, et al.
Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys. Infection, Genetics and Evolution
2013; 18: 125–131.
Park SY, et al.
Developing high-throughput HIV incidence assay with pyrosequencing platform. Journal of Virology
2014; 88: 2977–2990.
Cousins MM, et al.
Analysis of HIV using a high resolution melting (HRM) diversity assay: automation of HRM data analysis enhances the utility of the assay for analysis of HIV incidence. PLoS ONE
2012; 7: e51359.
Laeyendecker O, et al.
HIV incidence determination in the United States: a multiassay approach. Journal of Infectious Diseases
2013; 207: 232–239.
Mastro TD, et al.
Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward. Journal of HIV/AIDS Surveillance and Epidemiology
2010; 2: 1–14.
Keating SM, et al.
Lower-sensitivity and avidity modifications of the vitros anti-HIV 1 + 2 assay for detection of recent HIV infections and incidence estimation. Journal of Clinical Microbiology
2012; 50: 3968–3976.
Masciotra S, et al. Antibody avidity-based assay for identifying recent HIV-1 infections based on genetic systemsTM1/2 Plus O EIA. 17th Conference on Retroviruses and Opportunistic Infections, 16–19 February 2010, San Francisco 2010.
Curtis KA, et al.
Evaluation of a multiplex assay for estimation of HIV-1 incidence. PLoS ONE
2013; 8: e64201.
Kassanjee R, et al.
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS
2014; 28: 2439–2449.
Duong YT, et al.
Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes. PLoS ONE
2015; 10: e0114947.
Chawla A, et al.
Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. Journal of Clinical Microbiology
2007; 45: 415–420.
Suligoi B, et al.
Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays. Journal of Clinical Microbiology
2011; 49: 2610–2613.
Barin F, et al.
Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. Journal of Clinical Microbiology
2005; 43: 4441–4447.
Shepherd SJ, et al.
Development of an avidity assay for detection of recent HIV infections. Journal of Virological Methods
2015; 217: 42–49.
Wilson KM, et al.
Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations. AIDS
2004; 18: 2253–2259.
Schupbach J, et al.
Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation. PLoS Medicine
2007; 4: e343.
Li H, et al.
A simple and inexpensive particle agglutination test to distinguish recent from established HIV-1 infection. International Journal of Infectious Diseases
2007; 11: 459–465.
Kothe D, et al.
Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. Journal of Acquired Immune Deficiency Syndrome
2003; 33: 625–634.
Suligoi B, et al.
Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. Journal of Clinical Microbiology
2002; 40: 4015–4020.